GTHP (Guided Therapeutics) Other Current Liabilities: $0.65 Mil (As of Mar. 2026)


GTHP Guided Therapeutics Inc GTHP
18 GF Score
Price $0.28
! 4 Warning Signs
View Full Analysis

What is Guided Therapeutics Other Current Liabilities?

Guided Therapeutics GTHP +14.29% 18 Other Current Liabilities is $0.65 Mil as of Mar. 2026. GuruFocus rates GTHP with a GF Score™ of 18/100. The stock has 4 warning signs investors should review.

Guided Therapeutics's other current liabilities for the quarter that ended in Mar. 2026 was $0.65 Mil.

Guided Therapeutics's quarterly other current liabilities increased from Sep. 2025 ($0.60 Mil) to Dec. 2025 ($1.15 Mil) but then declined from Dec. 2025 ($1.15 Mil) to Mar. 2026 ($0.65 Mil).

Guided Therapeutics's annual other current liabilities increased from Dec. 2023 ($0.43 Mil) to Dec. 2024 ($0.57 Mil) and increased from Dec. 2024 ($0.57 Mil) to Dec. 2025 ($1.15 Mil).

Guided Therapeutics Other Current Liabilities Related Terms

Guided Therapeutics Other Current Liabilities Historical Data

* Premium members only.

The historical data trend for Guided Therapeutics's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Guided Therapeutics Other Current Liabilities Chart

Guided Therapeutics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.66 0.48 0.43 0.57 1.15

Guided Therapeutics Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.54 0.56 0.60 1.15 0.65
GTHP
18GF Score
Guided Therapeutics Inc GTHP
Other Current Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Guided Therapeutics Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

What does a Other Current Liabilities of $0.65 Mil mean?
Guided Therapeutics (GTHP) has a Other Current Liabilities of $0.65 Mil as of Mar. 2026. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Guided Therapeutics.
Is Guided Therapeutics' Other Current Liabilities too high?
Guided Therapeutics' current Other Current Liabilities is $0.65 Mil. Overall, Guided Therapeutics has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Guided Therapeutics' Other Current Liabilities compare to CTSO and IRIX?
Guided Therapeutics' Other Current Liabilities of $0.65 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for a Medical Devices & Instruments company?
A good Other Current Liabilities depends on the Medical Devices & Instruments industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Guided Therapeutics. Guided Therapeutics's current Other Current Liabilities is $0.65 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Guided Therapeutics stock overvalued right now?
Guided Therapeutics (GTHP) has a current Other Current Liabilities of $0.65 Mil. The current Other Current Liabilities is $0.65 Mil. Guided Therapeutics' overall GF Score™ is 18/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For Guided Therapeutics (GTHP), the current Other Current Liabilities is $0.65 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Guided Therapeutics Business Description

Address 5835 Peachtree Corners East, Suite B, Peachtree Corners, GA, USA, 30092
Guided Therapeutics Inc is a medical technology company. It is engaged in developing medical devices that have the potential to improve healthcare. Its primary focus is the sales and marketing of its LuViva Advanced Cervical Scan non-invasive cervical cancer detection device and the extension of its cancer detection technology into other cancers, including esophageal. The company generates revenue from the sale of medical devices.
18GF Score

Get the complete analysis for GTHP

Other Current Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.28
Price